Susquehanna International Group, LLP Biovie Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$0.4 - $0.56 $116,800 - $163,520
-292,000 Reduced 94.71%
16,300 $6,000
Q1 2024

May 07, 2024
BUY
$0.53 - $1.89 $120,310 - $429,030
227,000 Added 279.21%
308,300 $163,000
Q4 2023

Feb 14, 2024
BUY
$1.22 - $5.24 $75,030 - $322,260
61,500 Added 310.61%
81,300 $102,000
Q3 2023

Nov 14, 2023
BUY
$2.75 - $5.17 $54,450 - $102,366
19,800 New
19,800 $67,000
Q1 2023

May 16, 2023
BUY
$4.89 - $10.53 $92,421 - $199,017
18,900 New
18,900 $152,000

Others Institutions Holding BIVI

# of Institutions
5
Shares Held
340K
Call Options Held
0
Put Options Held
0
View Full List

About BIOVIE INC.

BIVI Quotes by TradingView
  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $92M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email